Nenutil Rudolf ( search by name in IS MU /auth )

Body na spoluautora Body za publikaci pro MU Odkaz ISVaV
3,40 16,99 Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status
0,90 5,40 Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer
1,05 8,42 Výsledky retrospektivní analýzy cílené léčby metastatického karcinomu prsu trastuzumabem v MOÚ. Identifikace prediktivních faktorů.
0,89 7,14 Identification of alphaB-crystallin, a biomarker of renal cell carcinoma by SELDI-TOF MS
2,27 13,60 Expression pattern of HLA class I antigens in renal cell carsinoma and primary cell line cultures: Methodological implications for immunotherapy
0,00 0,00 Sérový HER-2/neu v průběhu terapie Herceptinem u nemocných s karcinomem prsu
0,37 2,62 Molekulární taxonomie a prediktivní systémy karcinomu prsu definované na základě profilů genové exprese
0,97 5,82 MDM2 SNP309 does not associate with elevated MDM2 protein expression or breast cancer risk
0,81 4,03 Prognostic significance of tumor-infiltrating cytotoxic T-cells in colorectal cancer
4,51 36,05 Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression
0,00 0,00 Colon carcinoma and the possible significance of T-cell population, including FOXP3-positive lymphocytes
14,79 88,72 THE IMPACT OF SELECTED CELL SURVIVAL REGULATORS (OF AKT-2, BCL-2, CD29, PKC-DELTA AND SURVIVIN) ON PREDICTION OF CLINICAL OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
0,27 2,67 Identifikace potenciálních biomarkerů karcinomů prsu metodou SELDI-TOF MS
12,50 50,01 Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis
4,82 33,72 Clinicopathological correlations of cyclooxygenase-2, MDM2, and p53 expressions in surgically resectable pancreatic invasive ductal adenocarcinoma.
0,00 0,00 Lymphocyte showing the phenotype of regulatory T-cells infiltrate colon carcinoma
0,00 0,00 TIL-CTL, predikce prežití u pacientů s kolorektálním karcinomem, stadium II.
0,00 0,00 Tumor-infiltrating cytotoxic T-cells predict outcome in colorectal carcinoma, clinical stadium II.
Back
(c) Michal Bulant, 2011